Skip to main content

Abstract

Some metals with striking properties have been used for the development of different complexes with activity against malignant cells. Due to difficulties in early diagnosis of gallbladder cancer (GBC) the main treatment option is chemotherapy. In this line of research, ruthenium complexes represent a less toxic alternative that others metal complexes such as cisplatin. The aim of this study was to evaluate the effect of a novel ruthenium complex in activation of apoptosis in a cell lineG-415. Our results show an activity of inducing cell death and over-expression of pro-apoptotic transcripts.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

References

  1. RajveerHundal and Eldon A Shaffer. (2014) Gallbladder cancer: epidemiology and outcome. Clinical Epidemiology 6: 99–109. doi:10.2147/CLEP.S37357

  2. Andrew X. Zhu,Theodore S. Hong, Aram F. Hezel, y David A. Kooby. (2010). Current Management of Gallbladder Carcinoma. The Oncologist, 168–181 doi:10.1634/theoncologist.2009-0302

  3. Dr. Mario Uribe M, Dr. Claudio Heine T, Dr. Freddy Brito M, Dra. Diana Bravo L. (2013). Gallbladder Cancer: An Update Revista Médica Clínica Las Condes. 638-643

    Google Scholar 

  4. Claire S. Allardyce and Paul J. Dyson. (2001). ruthenium in medicine current clinical uses and future prospects. Platinum Metals Review.

    Google Scholar 

  5. L Trynda-Lemiesz. (2004) Interaction of an anticancer ruthenium complex HInd[RuInd2Cl4] with cytochrome c. 199-205. Acta Biochimica Polonica.

    Google Scholar 

  6. Brabec V, and Nováková O. (2006) DNA binding mode of ruthenium complexes and relationship to tumor cell toxicity. Drug Resistance Updates. PMID: 16790363

    Google Scholar 

  7. Yadav A, Janaratne T, MacDonnell FM et al. (2013) Regression of lung cancer by hypoxia-sensitizing ruthenium polypyridyl complexes. Molecular Cancer Therapeutics 643-53. doi: 10.1158/1535-7163.MCT-12-1130.

  8. ChanchalBhaumik, S. D. (2010). Synthesis, Characterization, Photophysical, and Anion-Binding Studies of Luminescent HeterolepticBis-Tridentate Ruthenium(II) Complexes Based on 2,6-Bis(Benzimidazole-2-yl)Pyridine and 40. Inorganic Chemistry, 5049 – 5062, doi: 10.1021/ic100138s.

  9. Kenneth J. Livak and Thomas D. Schmittgen. (2001) Analysis of Relative Gene Expression Data Using RealTime Quantitative PCR and the 2(-∆∆Ct)Method. Methods. 402–408 doi:10.1006/meth.2001.1262

  10. Rubie C, Kempf K, Hans J, Su T, Tilton B, Georg T, Brittner B, Ludwig B, Schilling M. (2005) Housekeeping gene variability in normal and cancerous colorectal, pancreatic, esophageal, gastric and hepatic tissues. Molecular and Cellular Probes 101-9 PMID: 15680211

    Google Scholar 

  11. Susan Elmore. (2007) Apoptosis: A Review of Programmed Cell Death. Toxicologic Pathology, 495-516 doi: 10.1080/01926230701320337

  12. Linlin Li, Wenqiang Cao, Wenjie Zheng, Cundong Fana and Tianfeng Chen. (2012). Ruthenium complexes containing 2,6-bis(benzimidazolyl)pyridine derivatives induce cancer cell apoptosis by triggering DNA damage-mediated p53 phosphorylation. Dalton Transactions, 41, 12766-12772, doi: 10.1039/C2DT30665D

  13. Lima AP, Pereira FC, Almeida MA, Mello FM, Pires WC, Pinto TM, Delella FK, Felisbino SL, Moreno V, Batista AA, de Paula Silveira-E Lacerda. (2014). Cytoxicity and apoptotic mechanism of ruthenium(II) amino acid complexes in sarcoma-180 tumor cells. PLoS One, doi: 10.1371/journal.pone.0105865.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hernán Villota .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer Nature Singapore Pte Ltd.

About this paper

Cite this paper

Villota, H., Pizarro, S., Gajardo, F., Delgadillo, Á., Cortés-Mancera, F., Bernal, G. (2017). Apoptosis induced by a novel Ruthenium II complex in a Gallbladder carcinoma cell line. In: Torres, I., Bustamante, J., Sierra, D. (eds) VII Latin American Congress on Biomedical Engineering CLAIB 2016, Bucaramanga, Santander, Colombia, October 26th -28th, 2016. IFMBE Proceedings, vol 60. Springer, Singapore. https://doi.org/10.1007/978-981-10-4086-3_75

Download citation

  • DOI: https://doi.org/10.1007/978-981-10-4086-3_75

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-10-4085-6

  • Online ISBN: 978-981-10-4086-3

  • eBook Packages: EngineeringEngineering (R0)

Publish with us

Policies and ethics